Neuralink’s brain-computer interface technology also has been discussed for other potential uses, for example, in mental health treatments for anxiety, depression or post-traumatic stress disorder where targeted nerve stimulation could help improve the function of poorly regulated brain areas.

Elon Musk’s Neuralink has selected Miami as a clinical trial site for its brain-computer interface, the second U.S. site to participate in the groundbreaking research to aid people with

Musk’s startup company Neuralink has tapped the University of Miami’s Miller School of Medicine to be the second site in the country to test whether its brain chip can give people who are paralyzed the ability to use mind to wirelessly control computers, smartphones and other electronic devices.

Neuralink selected the University of Miami Miller School of Medicine as its second site to conduct clinical trials on the innovative idea. Levi is a neurosurgeon and clinical director for the school.

The University of Miami on Monday announced that it will be the second U.S.-based site for Elon Musk’s Neuralink’s PRIME Study.